VILLERE ST DENIS J & CO LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
VILLERE ST DENIS J & CO LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$26,254,607
-24.0%
438,161
-8.6%
2.24%
-10.5%
Q2 2023$34,568,128
-2.3%
479,447
-0.3%
2.50%
-2.8%
Q1 2023$35,368,162
+109443.0%
480,807
-0.5%
2.57%
+2.1%
Q4 2022$32,287
-99.9%
483,347
-1.6%
2.52%
-25.1%
Q3 2022$42,289,000
-4.4%
491,107
-1.0%
3.37%
+1.8%
Q2 2022$44,255,000
-23.0%
496,028
-2.9%
3.31%
-3.2%
Q1 2022$57,464,000
-28.3%
510,843
-1.6%
3.41%
-25.7%
Q4 2021$80,162,000
+2.0%
518,988
-8.0%
4.60%
+0.4%
Q3 2021$78,625,000
+0.8%
564,349
-5.1%
4.58%
+9.6%
Q2 2021$77,976,000
-4.8%
594,380
+10.7%
4.18%
-6.8%
Q1 2021$81,869,000
+28.2%
537,028
-16.4%
4.48%
+16.2%
Q4 2020$63,854,000
+1.0%
642,073
-3.2%
3.85%
-9.4%
Q3 2020$63,233,000
-12.7%
663,383
+2.4%
4.25%
-18.1%
Q2 2020$72,441,000
+56.7%
647,668
+1.9%
5.19%
+31.7%
Q1 2020$46,232,000635,7583.94%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knott David M Jr 115,000$8,4593.32%
VILLERE ST DENIS J & CO LLC 480,807$35,368,1622.57%
Chicago Capital, LLC 449,508$33,065,8221.64%
RICE HALL JAMES & ASSOCIATES, LLC 288,345$21,210,6811.20%
Smith, Graham & Co., Investment Advisors, LP 65,163$4,793,3900.58%
Stephens Investment Management Group LLC 455,089$33,476,3470.56%
CARDINAL CAPITAL MANAGEMENT LLC /CT 201,993$14,858,6050.53%
WOODSTOCK CORP 52,604$3,869,5500.49%
Court Place Advisors, LLC 15,533$1,142,6070.41%
Jackson Creek Investment Advisors LLC 12,726$9360.39%
View complete list of LIGAND PHARMACEUTICALS INC shareholders